CClinicalTrials.gg
Status unknownNCT02615236Updated Nov 16, 2018

Prospective Evaluation of Perineal Ultrasound in Thr Delivery Room to Improve the Diagnosis of OASIS

An interventional study of perineal ultrasound and Clinical diagnosis in Episiotomy, sponsored by Ain Shams University. Status unknown at 1 site in Egypt. Open to female participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-11-16.

Sponsored by Ain Shams University · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Nov 2018), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
Female
01

Study summary

The aim of the study is to evaluate the role of routine perineal scan using 2D ultrasound immediatly after delivery to diagnose hidden perineal trauma that might affect patient's fecal continance

Read the detailed description

In countries where there is high prevalence of doing episiotomy in primiparous women, the incidence of sustained obstetric anal sphincter injuries is increasing.

When the tear extend beyond the external anal sphincter its called 'OASIS' that might lead to either immediate of delayed anal incontinence. Anal incontinence is associated with significant medical, hygiene and social problems. Use of perineal ultrasound as a bedside test immediately after vaginal delivery could improve the diagnosis and determining the degree of these perineal traumas. This increased detection could lead to improved primary repair of the external and internal anal sphincter resulting in reduced rates of anal incontinence and improved quality of life for women

02

Conditions studied

  • Episiotomy
03

In context

Lead sponsor

Ain Shams University is the lead sponsor of 1,876 studies on the registry; 423 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • primiparous women immediately after vaginal delivery

Exclusion criteria

Exclusion Criteria:

  • history of anal incontinence
  • previous anal sphincteric injuries
  • previous anal surgery
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    PERINEAL ULTRASOUND

    Perineal ultrasound with a bedside scanner by inserting a the probe into the perineum and reviewed in real-time

    Device: perineal ultrasound

  • Active comparator
    Clinical diagnosis

    Diagnosis of OASIS will be clinically

    Procedure: Clinical diagnosis

Interventions

  • Deviceperineal ultrasound

    transvaginal probe will be used to scan the perineum immediately after vaginal delivery in primiparous women

  • ProcedureClinical diagnosis

    diagnosis of OASIS clinically

06

What researchers measure

Primary outcomes

  1. anal incontinence

    patients will be reviewed for anal incontinence 3 months after delivery

    Time frame: 3 months after delivery

Secondary outcomes

  1. pain score

    visual analogue scale will be used

    Time frame: 3 and 12 month after delivery

  2. questionnaire for effect on quality of life

    questionnaire will be used to asses how anal incontinence affect the quality of life

    Time frame: 3 and 12 month after delivery

07

Study locations

1 site
  • Faculty of Medicine, Ain Shams University
    Cairo, Al Qahirah, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 16, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02615236
Lead sponsor
Ain Shams University
Responsible party
Ahmed Mohamed El Kotb Abdel Fattah (Dr. Ahmed Kotb, Ain Shams University) — Principal investigator
First posted
Nov 26, 2015
Start date
Jun 2016
Primary completion
Dec 2018 (estimated)
Completion
Dec 2018 (estimated)
Last update
Nov 16, 2018

Study contacts

Ahmed kotb, MD
principal investigator · Ain Shams University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion